Affordable Care Act

Johnson & Johnson CEO: Drugmakers Want Higher Government, Insurance Payments

J&J executive Alex Gorsky says that while pharma firms are pleased at reforms, more change is needed.

Pharmaceutical companies are pleased that health-care reform means more patients have insurance and will be encouraged to take their medicine to avoid costly hospitalizations.

But, as Johnson & Johnson chief executive officer Alex Gorsky said Tuesday, drugmakers want private insurers or government programs such as Medicare and Medicaid to pay them for those drugs at a prices closer to their choosing.

Your rating: None Average: 4.5 (2 votes)

Affordable Care Act, Pharma Value Proposition Among Top Health Issues of 2013

A new intelligence report looks into the top 10 issues most likely to impact the medical industry and pharmaceutical firms.

As the health industry undertakes a full transition to meet requirements of the Affordable Care Act (ACA) and to prepare for a shift in market dynamics, PwC's Health Research Institute (HRI) today published its annual list of the Top Health Industry Issues for 2013.  According to PwC US, the pace is certain to quicken in 2013 with the effects of technology, consumerism, budgetary pressures and the ACA converging on a sector that represents nearly one-fifth of the economy.

Your rating: None Average: 3 (1 vote)
Syndicate content